NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Biovet logo
Biovet S.A. Laboratories, a Spanish animal-nutrition company, has established a small office in Research Triangle Park to better serve the North American market.
Fennec logo
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy and Fast Track designations to Fennec Pharma’s drug designed to protect the hearing of children undergoing chemotherapy.
Grifols Clayton, NC site
Grifols, already the largest private employer in Johnston County, is about to get even bigger.
RTP Rotary Club - STEAM: Changing the World Event
On April 20, the Rotary Club of Research Triangle Park will host its first STEAM: Changing the World Event.

North Carolina is one of five states consistently recognized for its specialized life science industry. The state’s strong network of life science companies, universities and skilled workforce provide a strong advantage for companies of all sizes and stages of development. Statewide, North Carolina has more than 700 life science companies with 63,000 employees, and employment within life sciences is growing at 6.6 percent – triple the national average.

MedPharm logo
Two years after launching its U.S. subsidiary MP Pharma Services in Research Triangle Park, MedPharm has expanded its workforce and invested nearly $1M in new technology at the R&D facility. The U.K.-based company provides performance testing of topical and transdermal drug formulations and other contract services.



NCBiotech's RTP office closed at 2 p.m. on Monday, March 12 due to winter weather conditions. Many of us may still be working remotely, so please try us on email.

On Tuesday, the RTP office will open at 10 a.m.

Please check back for updates from the regional offices.

Durolane packaging
Bioventus, a global orthobiologics company based in Durham, has launched Durolane, its single-injection, hyaluronic acid (HA) joint lubricant for treating knee osteoarthritis pain, following FDA approval last summer.
G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reported positive top-line data from a Phase 2a trial of trilaciclib, its potential therapy for patients who are taking chemotherapy for small-cell lung cancer.
Five “alumni” companies of the Council for Entrepreneurial Development reported major progress at the CED’s Life Sciences Conference in Raleigh.
Ann Whitaker Novoclem Therapeutics
As CEO of Durham startup Novoclem Therapeutics, long-time pharmaceutical executive Anne Whitaker says she’s involved in a personal battle.
CED Venture Capitalists Session
It’s a classic question in the venture capital industry. When weighing which companies to fund, should investors favor good management teams or strong technologies and products? A panel of venture capitalists was split on that question at the Council for Entrepreneurial Development’s Life Science Conference in Raleigh.
Keith Vodrazka Cool Planet
Emerging technologies featured on the second day of the 2018 Ag Biotech Summit focused on soil health.
North Carolina, rich in scientific expertise and supporting resources, is one of the nation’s best places to start a life science enterprise, a panel of early stage company entrepreneurs agreed at the CED Life Science Conference in Raleigh.
AgBiotech Summit Ann Bartuska
“How do we take advantage of this new world of biotechnology” affecting agriculture, asked Ann Bartuska, Ph.D., vice president of Land, Water, and Nature with Resources for the Future at the 2018 AgBiotech Summit. “There are a lot of opportunities in emerging technologies we have yet to capitalize on.”